Optogenetic and chemogenetic therapies for epilepsy (2020)

First Author: Walker M
Attributed to:  Gene therapy for refractory epilepsy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2019.107751

PubMed Identifier: 31494141

Publication URI: http://europepmc.org/abstract/MED/31494141

Type: Journal Article/Review

Parent Publication: Neuropharmacology

ISSN: 0028-3908